Skip to main content

Treximet News

FDA Medwatch Alert: Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke

[Posted 07/09/2015] ISSUE:  FDA is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on ...

FDA Approves Treximet (sumatriptan and naproxen sodium) for Migraine in Pediatric Patients

MORRISTOWN, NJ – May 15, 2015 – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Tre...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine

Treximet patient information at Drugs.com